Advancing 3D-printed medical implants depends on the steady progress of leading-edge printer technologies, as well as the skillful development of the raw materials used...
Positive high-level results from the TROPION-Lung01 Phase III trial showed datopotamab deruxtecan (Dato-DXd) demonstrated a statistically significant improvement for the dual primary endpoint of...
Fresenius Kabi announced the immediate availability in the U.S. of its citrate-free adalimumab biosimilar IDACIO® (adalimumab-aacf) for use in the treatment of chronic autoimmune diseases for all...
CorEvitas, LLC, the gold-standard provider of real-world evidence solutions for the life sciences industry, announced that it has received the 2023 BOBI (Best of...
